Internet-based training for clinicians could help lower antibiotic prescribing rates for acute respiratory tract infections by as much as 62%, according to British researchers.
Patients' pathogen acquisition was reduced with Chlorhexidine gluconate 2% w/v impregnated pad, and intranasal mupirocin ointment - Study published in New England Journal of Medicine confirms universal decolonization of ICU patients reduces bloodstream infections by 44%.
A new test gives reliable results in just 75 minutes, speeding up combat actions. Since Methicillin-resistant staphy lococcus aureus (MRSA) has developed resistance to antibiotic treatments, infections have become a dreaded occurrence in hospitals worldwide.
‘This is a dramatic demonstration that medical genomics is no longer a technology of the future – it is a technology of the here and now' Report: Mark Nicholls
A recent webinar, hosted by the American Association of Clinical Chemistry, featured doctors Duane Newton of the University of Michigan and Susan Novak-Weekly of Kaiser Permanente.
The use of in-line filters for infusion therapy significantly lowers the rate of severe complications in children aged between 0-18 years being treated in intensive care units, according to a new study from the Paediatrics Clinic at Hannover Medical School (MHH). The study also confirmed that the number of cases of systemic inflammatory response syndrome, SIRS, dropped substantially through the…
As in so many European countries, nosocomial infections have hit the headlines in Germany over and over again in recent years – as when three premature babies died in a Bremen neonatal clinic in 2011.
Hospital acquired infections (HAIs) are among the most common complications during a hospital and care home stay in the West (although they also occur in developing countries, with even an assumed higher incidence), causing enormous strain for those affected as well as high follow-on costs for healthcare systems.
Scientists state concern for both human and environmental health from a very commonly used antibacterial/antifungal agent. Brenda Marsh reports
Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) doubled at academic medical centers in the U.S. between 2003 and 2008, according to a report published in the August issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
Prevention is better than a fight against an infected wound – but, to avoid a battle you must know your enemy – and the wound’s infection risk level. Unfortunately, there are no generally accepted definitions for those risk levels. Now, the introduction of a new clinical assessment score – named W.A.R. (wound at risk) – which makes standardised classification of ‘risky’ wounds…
Alere introduced its new PBP2a test, a rapid, lateralflow assay that detects the PBP2a protein found in MRSA directly from Staphylococcus aureus isolates. It is a costeffective, targeted approach to identifying MRSA, the firm points out. Providing results in five minutes, the assay uses samples from cultures (wound, skin, urine, etc.) and has builtin quality controls on every test strip.
Bacteria, viruses and fungi are killed on copper surfaces within seconds. This powerful germicidal effect, termed ‘contact killing’, is increasingly noted by hospitals due to several recent studies that confirm its antimicrobial effects.
Scientists in Scotland have developed a new test using a strip with electrical sensors that can show whether wounds or lesions have been infected with bacteria, including MRSA, Mark Nicholls reports. The hand-held test provides rapid results and allows almost immediate detection of bacteria, which means patients can be given more effective drugs much quicker and speed up their recovery.
With complementary portfolios, GlaxoSmithKline (GSK) and B. Braun have been working together since mid- May to develop a complete one-stop system for the decontamination of MRSA patients
Hospital infection control specialists from across Europe, the Middle East and Africa are travelling to Liverpool to learn how an English hospital Trust has become a world leader in infection prevention and control, Mark Nicholls reports
Copper and its alloys reduce the rate of nosocomial infections in hospitals by 40%, according to an American study led by Michael Schmidt (University of South Carolina). For the first time in France, one hospital near Paris chose to bet on the antibacterial quality of copper on commonly touched items to lower risks of HAIs, which annually claim 3,500 lives in the country – comparable to the…
By integrating all necessary pre-analytical and analytical steps into one solution, the recently CE-marked Unyvero system, which is now commercially available in Europe, provides pathogen identification and antibiotic resistance marker information without needing expert staff and a sophisticated infrastructure, its manufacturer Curetis reports. Of even greater interest is its range of targets.
Worldwide, antibiotic resistance is one of the three major challenges for public health according to the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). What needs to be done? Anja Behringer reports.
In Europe, nosocomial infections cause about 25,000 deaths every year. Copper has strong antibiotic effects and may reduce hospital acquired infections.
In terms of health politics, no hospital-related subject is more explosive than hygiene. However, although this reaction is common across Europe, approaches towards tackling nosocomial infections varies among our EU countries. Karoline Laarmann reports from Germany and Jane MacDougall from France…
Bacteria are highly flexible when it comes to choosing a vehicle to enter a human body. During orthopaedic surgery, they may well settle on a prosthetic joint and cause immediate or delayed infections.
While researching bovine mastitis (an S. aureus infection that occurs in the cows’ udders), researchers led by Dr Mark Holmes at the University of Cambridge, UK, identified a new strain of methicillin-resistant Staphylococcus aureus (MRSA) which occurs both in human and dairy cow populations.